A pilot study comparing efficacy and safety of topical 3% minoxidil solution with topical 3% minoxidil solution combined with topical 0.25% finasteride solution in treatment of female pattern hair loss.
Phase 3
Completed
- Conditions
- Female pattern hair lossAndrogenetic alopecia
- Registration Number
- TCTR20160912002
- Lead Sponsor
- Division of Dermatology, Ramathibodi Hospital, Mahidol University
- Brief Summary
Not available
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- Completed
- Sex
- Female
- Target Recruitment
- 30
Inclusion Criteria
1.Healthy female subject
2.Diagnosis of female pattern hair loss
3.Agree to participate and signed informed consent form
Exclusion Criteria
1.History of hair transplant
2.Applying topical hair growth products within 2 weeks
3.Receiving light and laser treatment of the scalp within 3 months
4.Taking oral finasteride within 12 months
5.Taking dutasteride within 18 months
6.History of systemic illness
7.History of scalp diseases eg. seborrheic dermatitis, scalp infection.
8.Pregnancy or breast feeding
Study & Design
- Study Type
- Interventional
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method Efficacy of topical 3% minoxidil solution combined with 0.25% finasteride solution 6 months Hair count and hair diameter
- Secondary Outcome Measures
Name Time Method Safety of topical 3% minoxidil solution combined with 0.25% finasteride solution 6 months Erythema, Scaliness, Inflammation and Systemic side effects